Dr. Gendelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-4015Fax+1 402-559-8715
Education & Training
- Johns Hopkins UniversityResidency, Neurology, 1984 - 1985
- Johns Hopkins UniversityResidency, Internal Medicine, 1983 - 1984
- Johns Hopkins UniversityResidency, Neurology, 1982 - 1983
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1979 - 1981
- Pennsylvania State University College of MedicineClass of 1979
Certifications & Licensure
- NE State Medical License 1993 - 2026
- MD State Medical License 1982 - 1994
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Leukine (Sargramostim) for Parkinson's Disease Start of enrollment: 2013 Sep 01
- Biomarker Assessments of Leukine During Treatment of Parkinson's Disease Start of enrollment: 2019 Jan 30
Publications & Presentations
PubMed
- 861 citationsA call for transparent reporting to optimize the predictive value of preclinical researchStory C. Landis, Susan G. Amara, Khusru Asadullah, Christopher P. Austin, Robi Blumenstein
Nature. 2012-10-11 - 434 citationsDiagnostics for SARS-CoV-2 infections.Bhavesh D. Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D. Oleynikov, Wilson R. Blomberg
Nature Materials. 2021-02-15 - 352 citationsSelective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseAnamitra Ghosh, Avik Roy, Xiaojuan Liu, Jeffrey H. Kordower, Elliott J. Mufson
Proceedings of the National Academy of Sciences of the United States of America. 2007-11-20
Journal Articles
- EcoHIV Infection of Mice Establishes Latent Viral Reservoirs in T Cells and Active Viral Reservoirs in Macrophages That Are Sufficient for Induction of Neurocognitive ...Howard E Gendelman, Bruce Polsky, PLoS One
Press Mentions
- New Hope for HIV Cure: Dual Gene Editing ‘Eliminates’ Infection, Targets Protein That Helps Virus Enter BodyMay 3rd, 2023
- In the Search for an HIV Cure, a New Gene-Editing Strategy from Temple Scientists May Be a Game-ChangerMay 3rd, 2023
- Dual CRISPR Gene Editing Strategy Cures Animals of HIV-1May 2nd, 2023
- Join now to see all
Grant Support
- Therapeutics Core (Page 286)National Institute Of Mental Health2011–2012
- Nanoformulation Uptake, Release, Toxicology And Tissue DeliveryNational Institute On Drug Abuse2010–2012
- Nanoart Manufacture, Delivery And Pharmacokinetics For Optimizing Drug AdherenceNational Institute On Drug Abuse2010–2012
- AdministrationNational Institute On Drug Abuse2010–2012
- Neural Immunity In HIV DementiaNational Institute Of Neurological Disorders And Stroke2008–2012
- Nanomedicine And NeuroaidsNational Institute Of Neurological Disorders And Stroke2008–2012
- Macrophage-Based Nanoformulations Of Anti-Retroviral Therapy In NeuroaidsNational Institute Of Neurological Disorders And Stroke2008–2012
- Administrative CoreNational Institute Of Neurological Disorders And Stroke2008–2012
- Neuroprotective Immunity And HIV DementiaNational Institute Of Neurological Disorders And Stroke2007–2011
- Meth, HIV-1 And Glial CrosstalkNational Institute On Drug Abuse2008–2010
- Proteomics CoreNational Institute Of Neurological Disorders And Stroke2003–2007
- Protective Immunity In HIV DementiaNational Institute Of Neurological Disorders And Stroke2003–2007
- Pathways Of Neuronal Damage Involving Macrophage-Glia Interactions In VivoNational Institute Of Neurological Disorders And Stroke2003–2007
- Neuronal Immunity In HIV DementiaNational Institute Of Neurological Disorders And Stroke2003–2007
- Blood Brain Barrier Physiology And HIV DementiaNational Institute Of Neurological Disorders And Stroke2001–2007
- Training Program In NeurovirologyNational Institute Of Neurological Disorders And Stroke2002–2006
- Molecular Mechanisms Of HIV NeuropathogenesisNational Institute Of Neurological Disorders And Stroke1995–2006
- Core--Cell, Tissue And Animal FacilityNational Institute Of Mental Health2001–2002
- Infection Of Microglial Cells By HIV-1National Institute Of Neurological Disorders And Stroke1998–2002
- Neuronal Electrophysiology In HIV DementiaNational Institute Of Neurological Disorders And Stroke1997–2001
- Macrophage Mediated Neurotoxicity Of HIV 1 DementiaNational Institute Of Mental Health1999–2000
- HIV-1, Monocytes And The Blood/Brain BarrierNational Institute Of Neurological Disorders And Stroke1997–2000
- Macrophage Mediated Neurotoxicity Of HIV 1 DementiaNational Institute Of Mental Health1997–1998
- HIV 1, Monocytes And The Blood/Brain BarrierNational Institute Of Neurological Disorders And Stroke1997
Other Languages
- Russian, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: